U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243002) titled 'Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.' on Nov. 13.
Brief Summary: This non-interventional study (NIS) aims to evaluate effectiveness, persistence, treatment patterns, adverse events (AEs), and patient-reported experience (including adherence, treatment satisfaction, health-related quality of life [HRQoL], work productivity, and etc.), among HR+/HER2- stage II and III eBC patients treated with ribociclib + ET, and to evaluate AEs and patients-reported experience among HR+/HER2- stage II and III eBC patients treated with abemaciclib + ET, as per local label.
Study Start Date: Dec. 1...